Torthaí cuardaigh - Imre Noth
- 1 - 20 toradh as 83 á dtaispeáint
- Téigh chuig an gcéad leathanach eile
-
1
Peripheral blood biomarkers in idiopathic pulmonary fibrosis de réir Rekha Vij, Imre Noth
Foilsithe / Cruthaithe 2012Revisão -
2
Idiopathic pulmonary fibrosis: Early detection and referral de réir Justin M. Oldham, Imre Noth
Foilsithe / Cruthaithe 2014Revisão -
3
Integrating Genomics Into Management of Fibrotic Interstitial Lung Disease de réir Ayodeji Adegunsoye, Rekha Vij, Imre Noth
Foilsithe / Cruthaithe 2019Revisão -
4
Autoimmune-Featured Interstitial Lung Disease de réir Rekha Vij, Imre Noth, Mary E. Strek
Foilsithe / Cruthaithe 2011Artigo -
5
A Variant in the Promoter of<i>MUC5B</i>and Idiopathic Pulmonary Fibrosis de réir Yingze Zhang, Imre Noth, Joe G. N. Garcia, Naftali Kaminski
Foilsithe / Cruthaithe 2011Carta -
6
Association between MUC5B and TERT polymorphisms and different interstitial lung disease phenotypes de réir Rongrong Wei, Chong Li, Min Zhang, Yava Jones‐Hall, Jamie L. Myers, Imre Noth, Wanqing Liu
Foilsithe / Cruthaithe 2013Artigo -
7
Thyroid Disease Is Prevalent and Predicts Survival in Patients With Idiopathic Pulmonary Fibrosis de réir Justin M. Oldham, Disha Kumar, Cathryn Lee, Shruti Patel, Stephenie Takahashi-Manns, Carley Demchuk, Mary E. Strek, Imre Noth
Foilsithe / Cruthaithe 2015Artigo -
8
Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials de réir Joyce Lee, Harold R. Collard, Kevin J. Anstrom, Fernando J. Martínez, Imre Noth, Rhonda Roberts, Eric Yow, Ganesh Raghu
Foilsithe / Cruthaithe 2013Artigo -
9
-
10
A Placebo-Controlled Randomized Trial of Warfarin in Idiopathic Pulmonary Fibrosis de réir Imre Noth, Kevin J. Anstrom, Sara B. Calvert, João A. de Andrade, Kevin Flaherty, Craig S. Glazer, Robert J. Kaner, Mitchell A. Olman
Foilsithe / Cruthaithe 2012Artigo -
11
Utility of whole genome sequencing in assessing risk and clinically relevant outcomes for pulmonary fibrosis de réir David Zhang, Chad A. Newton, Binhan Wang, Gundula Povysil, Imre Noth, Fernando J. Martínez, Ganesh Raghu, David B. Goldstein, Christine Kim Garcia
Foilsithe / Cruthaithe 2022Artigo -
12
The UCSD shortness of breath questionnaire has longitudinal construct validity in idiopathic pulmonary fibrosis de réir Jeffrey J. Swigris, MeiLan K. Han, Rekha Vij, Imre Noth, Eric L. Eisenstein, Kevin J. Anstrom, Kevin K. Brown, Diane L. Fairclough
Foilsithe / Cruthaithe 2012Artigo -
13
Oral immunotherapy with type V collagen in idiopathic pulmonary fibrosis de réir David S. Wilkes, Terrence Chew, Kevin R. Flaherty, Sarah Frye, Kevin F. Gibson, Naftali Kaminski, Michael J. Klemsz, Wade Lange, Imre Noth, Katia Rothhaar
Foilsithe / Cruthaithe 2015Artigo -
14
Telomere Length and Use of Immunosuppressive Medications in Idiopathic Pulmonary Fibrosis de réir Chad A. Newton, David Zhang, Justin M. Oldham, Julia Kozlitina, Shwu‐Fan Ma, Fernando J. Martínez, Ganesh Raghu, Imre Noth, Christine Kim Garcia
Foilsithe / Cruthaithe 2018Artigo -
15
Computed Tomography Honeycombing Identifies a Progressive Fibrotic Phenotype with Increased Mortality across Diverse Interstitial Lung Diseases de réir Ayodeji Adegunsoye, Justin M. Oldham, Shashi Bellam, Steven M. Montner, Matthew M. Churpek, Imre Noth, Rekha Vij, Mary E. Strek, Jonathan H. Chung
Foilsithe / Cruthaithe 2019Artigo -
16
Association of Angiotensin Modulators With the Course of Idiopathic Pulmonary Fibrosis de réir Michael Kreuter, David J. Lederer, María Molina‐Molina, Imre Noth, Claudia Valenzuela, Lutz Frankenstein, Derek Weycker, Mark Atwood, Klaus-Uwe Kirchgaessler, Vincent Cottin
Foilsithe / Cruthaithe 2019Artigo -
17
Prevalence of hiatal hernia by blinded multidetector CT in patients with idiopathic pulmonary fibrosis de réir Imre Noth, Steven Zangan, Renato Soares, Anne Forsythe, Carley Demchuk, Shinichiro Takahashi, Shruti Patel, Mary E. Strek, Jerry A. Krishnan, Marco G. Patti, Heber MacMahon
Foilsithe / Cruthaithe 2011Artigo -
18
CT Findings, Radiologic-Pathologic Correlation, and Imaging Predictors of Survival for Patients With Interstitial Pneumonia With Autoimmune Features de réir Jonathan H. Chung, Steven M. Montner, Ayodeji Adegunsoye, Cathryn Lee, Justin M. Oldham, Aliya N. Husain, Heber MacMahon, Imre Noth, Rekha Vij, Mary E. Strek
Foilsithe / Cruthaithe 2017Artigo -
19
Circulating Plasma Biomarkers of Progressive Interstitial Lung Disease de réir Shehabaldin Alqalyoobi, Ayodeji Adegunsoye, A. Linderholm, Cara L. Hrusch, Claire C. Cutting, Shwu‐Fan Ma, Anne I. Sperling, Imre Noth, Mary E. Strek, Justin M. Oldham
Foilsithe / Cruthaithe 2019Carta -
20
PEAR1 regulates expansion of activated fibroblasts and deposition of extracellular matrix in pulmonary fibrosis de réir Yan Geng, Lin Li, Jie Yan, Kevin Liu, Aizhen Yang, Lin Zhang, Yingzhi Shen, Han Gao, Xuefeng Wu, Imre Noth, Yong Huang, Junling Liu, Xuemei Fan
Foilsithe / Cruthaithe 2022Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Medicine
Internal medicine
Lung
Idiopathic pulmonary fibrosis
Biology
Pathology
Gene
Genetics
Interstitial lung disease
Pulmonary fibrosis
Immunology
Disease
Fibrosis
Cohort
Gastroenterology
Genotype
Single-nucleotide polymorphism
Intensive care medicine
Oncology
Biochemistry
Confidence interval
Diffusing capacity
Genome-wide association study
Lung function
Proportional hazards model
Pulmonary function testing
Alternative medicine
Placebo
Vital capacity
Cancer research